These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: [Laparoscopic radical antegrade modular pancreatosplenectomy for left-sided pancreatic adenocarcinoma: analysis of 12 cases].
    Author: Xu XW, Zhang RC, Mou YP, Qian ZY, Huang CJ, Zhu QC, Jin WW, Zhou YC.
    Journal: Zhonghua Wai Ke Za Zhi; 2018 Mar 01; 56(3):212-216. PubMed ID: 29534416.
    Abstract:
    Objective: To evaluate the safety and feasibility of laparoscopic radical antegrade modular pancreatosplenectomy(Lap-RAMPS) for left-sided pancreatic adenocarcinoma. Methods: Clinical data of total 12 patients underwent Lap-RAMPS for left-sided pancreatic adenocarcinoma at Department of Gastrointestinal and Pancreatic Surgery, Zhejiang Provincial People's Hospital from March 2016 to August 2017 were reviewed retrospectively.There were 7 male patients and 5 female patients, with median age of 60.5 years old(47-68 years old). Abdominal enhanced CT, pancreatic MRI, PET-CT were performed on all patients to evaluate the lesion and exclude metastasis.Follow-up were done with out-patient clinic or telephone consultancy until October 2017. Results: All patients underwent pure Lap-RAMPS.The medium operative time was 250 minutes(180-445 minutes), and the blood loss was 150 ml(50-500 ml). The medium first flatus time and diet resumption time were 3.0 days(1-5 days) and 3.5 days(1-7 days) respectively.The medium postoperative hospital stay was 9 days(4-18 days). Morbidity occurred in 8 patients with gastric empty delay(n=1), bleeding(n=1), fluid collection(n=3). There was no mortality.The medium overall number of retrived lymph nodes was 15.6 and the positive rate was 41.7%. The R0 rate was 100%.The medium follow-up was 10 months.One patient was diagnosed as liver metastasis after 8 months and accepted chemotherapy.One patient died after 14 months for tumor recurrence and metastasis.Others survived without tumor recurrence or metasitasis. Conclusion: Lap-RAMPS is safe and feasible with accepted oncological outcomes for selected left side pancreatic adenocarcinoma under skilled hands. 目的：探讨腹腔镜根治性顺行模块化胰脾切除术(Lap－RAMPS)治疗胰腺体尾部腺癌的安全性和可行性。 方法：回顾性分析2016年3月至2017年8月在浙江省人民医院胃肠胰外科接受Lap－RAMPS的12例胰腺体尾部腺癌患者的临床资料。男性7例，女性5例；年龄范围47～68岁，中位年龄60.5岁。所有患者术前均行全腹部增强CT、胰腺MRI、PET－CT以准确评估病灶位置、大小、毗邻关系，并排除远处转移。术后随访采用门诊和电话随访的方式。 结果： 12例患者均顺利完成手术，无中转开腹或腹腔镜辅助手术。手术时间250 min(范围：180～445 min)，术中出血量150 ml(范围：50～500 ml)，术后2.0 d(范围：1～5 d)下床活动，术后3.0 d(范围：1～5 d)排气；首次进食流质时间3.5 d(范围：1～7 d)，术后住院时间9 d(范围：4～18 d)。随访截至2017年10月30日，术后发生并发症8例，其中胃排空延迟1例，腹腔积液3例，术后出血1例。无围手术期死亡。淋巴结清扫数目为15.6枚，淋巴结阳性率为41.7%。所有患者均获得R0切除。中位随访时间为10个月。1例患者术后8个月发现肝脏转移，继续静脉化疗；1例患者术后14个月死于肿瘤复发和肝脏转移；其余10例患者仍无瘤存活。 结论：在经验丰富的中心并严格掌握手术指征的情况下，Lap－RAMPS可能使胰腺体尾部腺癌患者获得生存获益。.
    [Abstract] [Full Text] [Related] [New Search]